This app is for sale. Asking price: $53,220
3.5x revenue
21 buyers saw this recently
0 offers made
Shotwise app icon

Shotwise

Wegovy, Ozempic, Mounjaro

Take control of your GLP-1 treatment journey with Shotwise, the ultimate companion app designed to simplify injection tracking and monitor your progress effortlessly. Shotwise helps you stay consistent, informed, and motivated.

Worldwide Release Date: January 9, 2025

Verified withRevenueCatFor Sale
#57 MRR
#84 Revenue
#23 in Health & Fitness
Transparency: 10/10

Star Ratings(124 ratings | avg ★ 4.6)

App Store (124 ratings)

us

4.7

101 ratings

gb

4.5

14 ratings

ca

5.0

4 ratings

nl

2.5

2 ratings

fr

5.0

1 rating

de

3.0

1 rating

br

5.0

1 rating

Last 28 days

Revenue

$1,265

AR

$15,180

MRR

$2,661

ARR

$31,932

Cash Flow Index

0.5x

Active Subscriptions

2,038

Active Trials

5

ARPAS

$0.62

Paid Subscriber Share (snapshot)

99.8%

Active Customers

951

New Customers

195

Subscription Penetration

214.3%

ARPU

$1.33

RPD

$1.33

ARPPU

$1.31

LTV

$13

MRR Growth (28d)

-5.7%

Revenue Growth (28d)

-6.5%

Subscriber Growth (28d)

-3.3%

All data is verified through RevenueCat. Last updated: Feb 2, 2026, 12:30:38 AM UTC.

App Screenshots

Shotwise screenshot 1
Shotwise screenshot 2
Shotwise screenshot 3
Shotwise screenshot 4
Shotwise screenshot 5

In-App Pricing

ShotWise Pro Annual$24.99
ShotWise Pro Annual$9.99
Shotwise Pro Annual$4.99

Tech Stack

Frontend
ExpoExpo

About This Listing

A GLP-1 shot tracker app, low maintenance, huge market and potential for improvement. Also potential for expanded revenue through GLP-1 affiliates that is a huge opportunity but one I haven’t had the time or bandwidth to explore.

Asking Price

$53,220

Sale Details

Business Operations Started

Jan 2025

Assets Included in Sale

Social media accounts

Source Code Included

Yes

Post-Sales Support

Yes, seller will provide support
Privacy Policy|Terms of Service